{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:32:38Z","timestamp":1783110758427,"version":"3.54.6"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Merz Therapeutics GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J NeuroEngineering Rehabil"],"DOI":"10.1186\/s12984-026-01895-x","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T14:03:15Z","timestamp":1769868195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Electrical or magnetic nerve stimulation enhance the BoNT\/A-mediated muscle paralysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Stefanie","family":"Honndorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"issue":"762","key":"1895_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1136\/pgmj.65.762.208","volume":"65","author":"TK Das","year":"1989","unstructured":"Das TK, Park DM. Effect of treatment with botulinum toxin on spasticity. Postgrad Med J. 1989;65(762):208\u201310.","journal-title":"Postgrad Med J"},{"issue":"6485","key":"1895_CR2","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1136\/bmj.290.6485.1857","volume":"290","author":"JS Elston","year":"1985","unstructured":"Elston JS, Russell RW. Effect of treatment with botulinum toxin on neurogenic blepharospasm. Br Med J (Clin Res Ed). 1985;290(6485):1857\u20139.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"11","key":"1895_CR3","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1136\/jnnp.57.11.1321","volume":"57","author":"S Hesse","year":"1994","unstructured":"Hesse S, Lucke D, Malezic M, et al. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry. 1994;57(11):1321\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1895_CR4","first-page":"219","volume":"19","author":"MZ Atassi","year":"1999","unstructured":"Atassi MZ, Oshima M. Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins. Crit Rev Immunol. 1999;19(3):219\u201360.","journal-title":"Crit Rev Immunol"},{"issue":"10","key":"1895_CR5","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1517\/14656566.2.10.1649","volume":"2","author":"SD Silberstein","year":"2001","unstructured":"Silberstein SD. Review of botulinum toxin type A and its clinical applications in migraine headache. Expert Opin Pharmacother. 2001;2(10):1649\u201354.","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"1895_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/mda.2002.24423","volume":"48","author":"WJ Binder","year":"2002","unstructured":"Binder WJ, Brin MF, Blitzer A, et al. Botulinum toxin type A (BOTOX) for treatment of migraine. Dis Mon. 2002;48(5):323\u201335.","journal-title":"Dis Mon"},{"issue":"2","key":"1895_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1124\/pr.116.012658","volume":"69","author":"M Pirazzini","year":"2017","unstructured":"Pirazzini M, Rossetto O, Eleopra R, et al. Botulinum neurotoxins: Biology, Pharmacology, and toxicology. Pharmacol Rev. 2017;69(2):200\u201335.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"1895_CR8","doi-asserted-by":"publisher","first-page":"jrm00138","DOI":"10.2340\/16501977-2760","volume":"53","author":"P Kanovsky","year":"2021","unstructured":"Kanovsky P, Elovic EP, Munin MC, et al. Sustained efficacy of incobotulinumtoxina repeated injections for upper-limb post-stroke spasticity: A post hoc analysis. J Rehabil Med. 2021;53(1):jrm00138.","journal-title":"J Rehabil Med"},{"issue":"5","key":"1895_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2165\/00003495-200767050-00003","volume":"67","author":"WH Jost","year":"2007","unstructured":"Jost WH, Blumel J, Grafe S. Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia. Drugs. 2007;67(5):669\u201383.","journal-title":"Drugs"},{"issue":"5","key":"1895_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/WNF.0b013e3181f5329e","volume":"33","author":"BE Crowner","year":"2010","unstructured":"Crowner BE, Torres-Russotto D, Carter AR, et al. Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature. Clin Neuropharmacol. 2010;33(5):243\u20137.","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"1895_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/PHM.0b013e3181a5b056","volume":"88","author":"E Varghese-Kroll","year":"2009","unstructured":"Varghese-Kroll E, Elovic EP. Contralateral weakness and fatigue after high-dose botulinum toxin injection for management of poststroke spasticity. Am J Phys Med Rehabil. 2009;88(6):495\u20139.","journal-title":"Am J Phys Med Rehabil"},{"issue":"3","key":"1895_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2310\/7010.2006.00041","volume":"21","author":"EM Goldstein","year":"2006","unstructured":"Goldstein EM. Safety of high-dose botulinum toxin type A therapy for the treatment of pediatric spasticity. J Child Neurol. 2006;21(3):189\u201392.","journal-title":"J Child Neurol"},{"issue":"4","key":"1895_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.rehab.2018.08.004","volume":"62","author":"A Picelli","year":"2019","unstructured":"Picelli A, Santamato A, Chemello E, et al. Adjuvant treatments associated with botulinum toxin injection for managing spasticity: an overview of the literature. Ann Phys Rehabil Med. 2019;62(4):291\u201396.","journal-title":"Ann Phys Rehabil Med"},{"issue":"1","key":"1895_CR14","doi-asserted-by":"publisher","first-page":"jrm00134","DOI":"10.2340\/16501977-2753","volume":"53","author":"GE Francisco","year":"2021","unstructured":"Francisco GE, Balbert A, Bavikatte G, et al. A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: an international group consensus. J Rehabil Med. 2021;53(1):jrm00134.","journal-title":"J Rehabil Med"},{"key":"1895_CR15","doi-asserted-by":"publisher","first-page":"997913","DOI":"10.3389\/fneur.2022.997913","volume":"13","author":"JX Pan","year":"2022","unstructured":"Pan JX, Diao YX, Peng HY, et al. Effects of repetitive peripheral magnetic stimulation on spasticity evaluated with modified Ashworth scale\/Ashworth scale in patients with spastic paralysis: A systematic review and meta-analysis. Front Neurol. 2022;13:997913.","journal-title":"Front Neurol"},{"issue":"1","key":"1895_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/0269215514537915","volume":"29","author":"A Santamato","year":"2015","unstructured":"Santamato A, Micello MF, Panza F, et al. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial. Clin Rehabil. 2015;29(1):50\u20138.","journal-title":"Clin Rehabil"},{"issue":"1","key":"1895_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0304-3940(94)12124-9","volume":"201","author":"S Hesse","year":"1995","unstructured":"Hesse S, Jahnke MT, Luecke D, et al. Short-term electrical stimulation enhances the effectiveness of botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett. 1995;201(1):37\u201340.","journal-title":"Neurosci Lett"},{"issue":"5","key":"1895_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1191\/026921598668275996","volume":"12","author":"S Hesse","year":"1998","unstructured":"Hesse S, Reiter F, Konrad M, et al. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial. Clin Rehabil. 1998;12(5):381\u20138.","journal-title":"Clin Rehabil"},{"issue":"10","key":"1895_CR19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.2340\/16501977-0251","volume":"40","author":"A Baricich","year":"2008","unstructured":"Baricich A, Carda S, Bertoni M, et al. A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot. J Rehabil Med. 2008;40(10):870\u20132.","journal-title":"J Rehabil Med"},{"issue":"11","key":"1895_CR20","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/PHM.0b013e3181520449","volume":"86","author":"BS Kang","year":"2007","unstructured":"Kang BS, Bang MS, Jung SH. Effects of botulinum toxin A therapy with electrical stimulation on spastic calf muscles in children with cerebral palsy. Am J Phys Med Rehabil. 2007;86(11):901\u20136.","journal-title":"Am J Phys Med Rehabil"},{"issue":"2","key":"1895_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1113\/jphysiol.1962.sp006843","volume":"160","author":"R Hughes","year":"1962","unstructured":"Hughes R, Whaler BC. Influence of nerve-ending activity and of drugs on the rate of paralysis of rat diaphragm preparations by Cl. botulinum type A toxin. J Physiol. 1962;160(2):221\u201333.","journal-title":"J Physiol"},{"issue":"1","key":"1895_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0022-3565(25)31908-7","volume":"212","author":"LL Simpson","year":"1980","unstructured":"Simpson LL. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther. 1980;212(1):16\u201321.","journal-title":"J Pharmacol Exp Ther"},{"key":"1895_CR23","doi-asserted-by":"crossref","unstructured":"Picelli A, Filippetti M, Sandrini G et al. Electrical stimulation of injected muscles to boost botulinum toxin effect on spasticity: Rationale, systematic review and state of the Art. Toxins (Basel). 2021; 13(5).","DOI":"10.3390\/toxins13050303"},{"issue":"1","key":"1895_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5853\/jos.2019.03027","volume":"22","author":"SC Bao","year":"2020","unstructured":"Bao SC, Khan A, Song R, et al. Rewiring the lesioned brain: electrical stimulation for Post-Stroke motor restoration. J Stroke. 2020;22(1):47\u201363.","journal-title":"J Stroke"},{"issue":"4","key":"1895_CR25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.apmr.2018.10.016","volume":"100","author":"A Mahmood","year":"2019","unstructured":"Mahmood A, Veluswamy SK, Hombali A, et al. Effect of transcutaneous electrical nerve stimulation on spasticity in adults with stroke: A systematic review and Meta-analysis. Arch Phys Med Rehabil. 2019;100(4):751\u201368.","journal-title":"Arch Phys Med Rehabil"},{"key":"1895_CR26","doi-asserted-by":"crossref","unstructured":"Suputtitada A, Chatromyen S, Chen CPC et al. Best practice guidelines for the management of patients with Post-Stroke spasticity: A modified scoping review. Toxins (Basel). 2024; 16(2).","DOI":"10.3390\/toxins16020098"},{"issue":"2","key":"1895_CR27","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1021\/bi0356698","volume":"43","author":"JE Keller","year":"2004","unstructured":"Keller JE, Cai F, Neale EA. Uptake of botulinum neurotoxin into cultured neurons. Biochemistry. 2004;43(2):526\u201332.","journal-title":"Biochemistry"},{"issue":"1","key":"1895_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/mds.870120115","volume":"12","author":"R Eleopra","year":"1997","unstructured":"Eleopra R, Tugnoli V, De Grandis D. The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans. Mov Disord. 1997;12(1):89\u201394.","journal-title":"Mov Disord"},{"issue":"6","key":"1895_CR29","first-page":"431","volume":"38","author":"RK Elnaggar","year":"2020","unstructured":"Elnaggar RK, Alqahtani BA, Elbanna MF. Functional outcomes of botulinum neurotoxin-A injection followed by reciprocal electrical stimulation in children with cerebral palsy: A randomized controlled trial. Restor Neurol Neurosci. 2020;38(6):431\u201341.","journal-title":"Restor Neurol Neurosci"},{"issue":"2","key":"1895_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.23736\/S1973-9087.18.05196-1","volume":"55","author":"RK Elnaggar","year":"2019","unstructured":"Elnaggar RK, Elbanna MF. Evaluation of independent versus integrated effects of reciprocal electrical stimulation and botulinum toxin-A on dynamic limits of postural stability and ankle kinematics in spastic diplegia: a single-blinded randomized trial. Eur J Phys Rehabil Med. 2019;55(2):241\u201349.","journal-title":"Eur J Phys Rehabil Med"},{"issue":"3","key":"1895_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3233\/NRE-210088","volume":"49","author":"A Gottlieb","year":"2021","unstructured":"Gottlieb A, Boltzmann M, Schmidt SB, et al. Treatment of upper limb spasticity with inhibitory repetitive transcranial magnetic stimulation: A randomized placebo-controlled trial. NeuroRehabilitation. 2021;49(3):425\u201334.","journal-title":"NeuroRehabilitation"},{"issue":"4","key":"1895_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jht.2018.01.008","volume":"32","author":"Y Hirakawa","year":"2019","unstructured":"Hirakawa Y, Koyama S, Tanabe S, et al. Combined effects of botulinum toxin type A and repetitive transcranial magnetic stimulation with intensive motor training immediately after injection in a patient with chronic stroke: A case report. J Hand Ther. 2019;32(4):519\u201324.","journal-title":"J Hand Ther"},{"issue":"5\u20136","key":"1895_CR33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000365005","volume":"72","author":"N Yamada","year":"2014","unstructured":"Yamada N, Kakuda W, Kondo T, et al. Local muscle injection of botulinum toxin type a synergistically improves the beneficial effects of repetitive transcranial magnetic stimulation and intensive occupational therapy in post-stroke patients with spastic upper limb hemiparesis. Eur Neurol. 2014;72(5\u20136):290\u20138.","journal-title":"Eur Neurol"},{"key":"1895_CR34","doi-asserted-by":"crossref","unstructured":"Sami Elsaharty K, Salman AF, Fayed IH et al. The effect of the combined application of repetitive transcranial magnetic stimulation and local injection of botulinum neurotoxin versus their individual use in children with spastic diplegic cerebral palsy. Physiother Theory Pract. 2024:1\u201310.","DOI":"10.1080\/09593985.2024.2433596"},{"issue":"1","key":"1895_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12984-021-00811-9","volume":"18","author":"A Pascual-Valdunciel","year":"2021","unstructured":"Pascual-Valdunciel A, Hoo GW, Avrillon S, et al. Peripheral electrical stimulation to reduce pathological tremor: a review. J Neuroeng Rehabil. 2021;18(1):33.","journal-title":"J Neuroeng Rehabil"},{"key":"1895_CR36","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fneur.2019.00930","volume":"10","author":"VR Zschorlich","year":"2019","unstructured":"Zschorlich VR, Hillebrecht M, Tanjour T, et al. Repetitive peripheral magnetic nerve stimulation (rPMS) as adjuvant therapy reduces skeletal muscle reflex activity. Front Neurol. 2019;10:930.","journal-title":"Front Neurol"},{"key":"1895_CR37","unstructured":"Werner CSM, Wernicke S, Bryl B, Hesse S. Repetitive peripheral magnetic stimulation (rpMS) in combination with muscle stretch decreased the wrist and finger flexor muscle spasticity in chronic patients after CNS lesion. Int J Phys Med Rehabil. 2016:6."},{"issue":"6","key":"1895_CR38","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.apmr.2014.02.003","volume":"95","author":"C Krewer","year":"2014","unstructured":"Krewer C, Hartl S, Muller F, et al. Effects of repetitive peripheral magnetic stimulation on upper-limb spasticity and impairment in patients with spastic hemiparesis: a randomized, double-blind, sham-controlled study. Arch Phys Med Rehabil. 2014;95(6):1039\u201347.","journal-title":"Arch Phys Med Rehabil"},{"key":"1895_CR39","doi-asserted-by":"publisher","first-page":"1161532","DOI":"10.3389\/fneur.2023.1161532","volume":"14","author":"L Grosse","year":"2023","unstructured":"Grosse L, Spah MA, Borner C, et al. Addressing gross motor function by functional repetitive neuromuscular magnetic stimulation targeting to the gluteal muscles in children with bilateral spastic cerebral palsy: benefits of functional repetitive neuromuscular magnetic stimulation targeting the gluteal muscles. Front Neurol. 2023;14:1161532.","journal-title":"Front Neurol"},{"issue":"1","key":"1895_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12984-022-00985-w","volume":"19","author":"N El Nahas","year":"2022","unstructured":"El Nahas N, Kenawy FF, Abd Eldayem EH, et al. Peripheral magnetic theta burst stimulation to muscles can effectively reduce spasticity: a randomized controlled trial. J Neuroeng Rehabil. 2022;19(1):5.","journal-title":"J Neuroeng Rehabil"},{"key":"1895_CR41","doi-asserted-by":"crossref","unstructured":"Ambrosio F, Fitzgerald GK, Ferrari R et al. A murine model of muscle training by neuromuscular electrical stimulation. J Vis Exp. 2012(63):e3914.","DOI":"10.3791\/3914-v"},{"issue":"12","key":"1895_CR42","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/S0041-0101(01)00101-5","volume":"39","author":"KR Aoki","year":"2001","unstructured":"Aoki KR. A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice. Toxicon. 2001;39(12):1815\u201320.","journal-title":"Toxicon"},{"key":"1895_CR43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.toxicon.2013.05.004","volume":"71","author":"RS Broide","year":"2013","unstructured":"Broide RS, Rubino J, Nicholson GS, et al. The rat digit abduction score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis. Toxicon. 2013;71:18\u201324.","journal-title":"Toxicon"},{"issue":"1","key":"1895_CR44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12883-020-01702-7","volume":"20","author":"A Leon-Valenzuela","year":"2020","unstructured":"Leon-Valenzuela A, Palacios JS, Del Pino Algarrada R. IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy - a retrospective case series focusing on dosing and tolerability. BMC Neurol. 2020;20(1):126.","journal-title":"BMC Neurol"},{"issue":"2","key":"1895_CR45","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0006-8993(78)90409-2","volume":"153","author":"H Lundh","year":"1978","unstructured":"Lundh H. Effects of 4-aminopyridine on neuromuscular transmission. Brain Res. 1978;153(2):307\u201318.","journal-title":"Brain Res"},{"issue":"21","key":"1895_CR46","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1080\/09638288.2016.1219398","volume":"39","author":"D Intiso","year":"2017","unstructured":"Intiso D, Santamato A, Di Rienzo F. Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review. Disabil Rehabil. 2017;39(21):2123\u201333.","journal-title":"Disabil Rehabil"},{"issue":"1","key":"1895_CR47","doi-asserted-by":"publisher","first-page":"14746","DOI":"10.1038\/s41598-017-14997-3","volume":"7","author":"J Pingel","year":"2017","unstructured":"Pingel J, Nielsen MS, Lauridsen T, et al. Injection of high dose botulinum-toxin A leads to impaired skeletal muscle function and damage of the fibrilar and non-fibrilar structures. Sci Rep. 2017;7(1):14746.","journal-title":"Sci Rep"},{"issue":"6","key":"1895_CR48","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/bcpt.12351","volume":"116","author":"Y Torii","year":"2015","unstructured":"Torii Y, Goto Y, Nakahira S, et al. Comparison of systemic toxicity between botulinum toxin subtypes A1 and A2 in mice and rats. Basic Clin Pharmacol Toxicol. 2015;116(6):524\u20138.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1895_CR49","doi-asserted-by":"publisher","first-page":"100029","DOI":"10.1016\/j.toxcx.2020.100029","volume":"6","author":"S Cornet","year":"2020","unstructured":"Cornet S, Perier C, Kalinichev M. Optimization of the rat digit abduction score (DAS) assay: evaluation of botulinum neurotoxin activity in the gastrocnemius lateralis, peronei, and extensor digitorum longus. Toxicon X. 2020;6:100029.","journal-title":"Toxicon X"},{"issue":"3","key":"1895_CR50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0168-5597(92)90135-X","volume":"85","author":"JD Weissman","year":"1992","unstructured":"Weissman JD, Epstein CM, Davey KR. Magnetic brain stimulation and brain size: relevance to animal studies. Electroencephalogr Clin Neurophysiol. 1992;85(3):215\u20139.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"1895_CR51","first-page":"1","volume":"9","author":"AK Asbury","year":"1978","unstructured":"Asbury AK, Johnson PC. Pathology of peripheral nerve. Major Probl Pathol. 1978;9:1\u2013311.","journal-title":"Major Probl Pathol"},{"issue":"1","key":"1895_CR52","first-page":"231","volume":"7","author":"G Schalow","year":"2023","unstructured":"Schalow G. Classification and identification of human peripheral nerve fibers by conduction Velocity, nerve fiber diameter and natural firing patterns with consequences for CNS repair and Covid-19 infection treatment. Int J Med Clin Imaging. 2023;7(1):231\u2013314.","journal-title":"Int J Med Clin Imaging"},{"issue":"1","key":"1895_CR53","doi-asserted-by":"publisher","first-page":"7592","DOI":"10.1038\/s41598-020-64430-5","volume":"10","author":"LB Dahlin","year":"2020","unstructured":"Dahlin LB, Rix KR, Dahl VA, et al. Three-dimensional architecture of human diabetic peripheral nerves revealed by X-ray phase contrast holographic nanotomography. Sci Rep. 2020;10(1):7592.","journal-title":"Sci Rep"},{"key":"1895_CR54","unstructured":"Johannes K. Tuning sensory mechanotransduction to wind down neuropathic pain. Dissertation. Berlin: Free University of Berlin 2023."},{"issue":"1","key":"1895_CR55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40902-021-00297-4","volume":"43","author":"SH Byun","year":"2021","unstructured":"Byun SH, Ahn KM. Functional and electron-microscopic changes after differential traction injury in the sciatic nerve of a rat. Maxillofac Plast Reconstr Surg. 2021;43(1):12.","journal-title":"Maxillofac Plast Reconstr Surg"},{"issue":"1","key":"1895_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12868-016-0277-4","volume":"17","author":"M Sakita","year":"2016","unstructured":"Sakita M, Murakami S, Fujino H. Age-related morphological regression of myelinated fibers and capillary architecture of distal peripheral nerves in rats. BMC Neurosci. 2016;17(1):39.","journal-title":"BMC Neurosci"},{"issue":"2","key":"1895_CR57","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1462-5822.2008.01253.x","volume":"11","author":"A Couesnon","year":"2009","unstructured":"Couesnon A, Shimizu T, Popoff MR. Differential entry of botulinum neurotoxin A into neuronal and intestinal cells. Cell Microbiol. 2009;11(2):289\u2013308.","journal-title":"Cell Microbiol"},{"issue":"41","key":"1895_CR58","doi-asserted-by":"publisher","first-page":"35966","DOI":"10.1074\/jbc.M111.283879","volume":"286","author":"CB Harper","year":"2011","unstructured":"Harper CB, Martin S, Nguyen TH, et al. Dynamin Inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism. J Biol Chem. 2011;286(41):35966\u201376.","journal-title":"J Biol Chem"},{"issue":"2","key":"1895_CR59","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1083\/jcb.103.2.521","volume":"103","author":"JD Black","year":"1986","unstructured":"Black JD, Dolly JO. Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves. J Cell Biol. 1986;103(2):521\u201334.","journal-title":"J Cell Biol"},{"issue":"1\u20132","key":"1895_CR60","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuint.2007.04.031","volume":"52","author":"SZ Langer","year":"2008","unstructured":"Langer SZ. Presynaptic autoreceptors regulating transmitter release. Neurochem Int. 2008;52(1\u20132):26\u201330.","journal-title":"Neurochem Int"}],"container-title":["Journal of NeuroEngineering and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12984-026-01895-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12984-026-01895-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12984-026-01895-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T19:03:26Z","timestamp":1771959806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12984-026-01895-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1895"],"URL":"https:\/\/doi.org\/10.1186\/s12984-026-01895-x","relation":{},"ISSN":["1743-0003"],"issn-type":[{"value":"1743-0003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Studies were performed in full compliance with the European Communities Council Directive 2010\/63\/EU. Experimental procedures were approved by the local authority for the use of animals for scientific purposes (reference 2347-13-2022-35-G, Regional Council of Brandenburg).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors contributed to the article and approved the submitted version.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}